COc1cccc(C(CNc2ccc(S(=O)(=O)N3CCN(C)CC3)cc2[N+](=O)[O-])N(C)C)c1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?